Abstract | BACKGROUND: MATERIALS AND METHODS: The expressions of p53 (primary antibody CM5) and p21 Ki-ras (primary antibody F234) proteins were evaluated by immunohistochemisty in MX-induced tumors in Wistar rats. p53 expression was studied in 3 follicular adenomas, 29 follicular carcinomas and two C-cell carcinomas of thyroid glands. p21 Ki-ras expression was studied in 13 follicular carcinomas and one C-cell carcinoma. RESULTS: A weak expression of p53 protein (1-5% of tumor cells) observed in six follicular carcinomas (21%) and one C-cell carcinoma was not considered to be p53-positive. No expression of p21 Ki-ras was observed in any of the samples. CONCLUSION: These data indicate that p53 and Ki- ras proteins are not overexpressed in the MX-induced thyroid tumors in rats.
|
Authors | Pasi Hakulinen, Veli-Matti Kosma, Hannu Komulainen |
Journal | Anticancer research
(Anticancer Res)
2002 Mar-Apr
Vol. 22
Issue 2A
Pg. 703-6
ISSN: 0250-7005 [Print] Greece |
PMID | 12014640
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Carcinogens
- Furans
- Tumor Suppressor Protein p53
- 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone
- Proto-Oncogene Proteins p21(ras)
|
Topics |
- Animals
- Carcinogens
(toxicity)
- Furans
(toxicity)
- Proto-Oncogene Proteins p21(ras)
(biosynthesis)
- Rats
- Rats, Wistar
- Thyroid Neoplasms
(chemically induced, metabolism)
- Tumor Suppressor Protein p53
(biosynthesis)
|